Senzime AB

Senzime AB

SEZI · ST · Healthcare / Medical Devices

3.51SEK-0.09 (-2.50%)

Price History

Full chart

Market Stats

Previous Close3.60
Open3.65
Day Range3.45 – 3.67
52-Week Range2.35 – 6.24
Volume207.05K
Market Cap449.64M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.71
Dividend Yield0.00%
Beta0.43
50-Day Avg3.40
200-Day Avg4.32

About

Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue's opposition to carrying an alternating electrical current. It also provides additional products, including CliniSenz Analyzer and OnZurf Probe. The company has a strategic connectivity and licensing agreement with Masimo that grants Senzime the rights to use some of Masimo's intellectual property; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Philip Siberg
  • Employees59
  • HeadquartersVerkstadsgatan 8, Uppsala, Sweden, 753 23, Sweden
  • Websitehttps://www.senzime.com

Leadership

  • Mr. Philip SibergChief Executive Officer · b. 1973
  • Mr. Slavoljub GrujicicChief Financial Officer · b. 1970
  • Ms. Johanna TulkkiExecutive VP & COO · b. 1970
  • Mr. Anders JacobsonChief Scientific Officer · b. 1967
  • Ms. Paula TreutigerHead of Communication & Investor Relations · b. 1967
  • Mr. Michael NobleChief Marketing Officer · b. 1988
  • Ms. Catrin MolundExecutive Vice President of Business Development · b. 1970
  • Ms. Johanna FarisHead of Q/RA/S · b. 1975

Financials

Income Statement

Currency: SEK2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.23M1.29M2.35M1.31M1.69M1.71M1.82M298.34K1.24M541.15K152.63K1.63M189.00K3.21M6.71M9.34M10.98M14.03M35.75M58.48M104.02M
Growth (%)--42.13%+82.33%-44.35%+28.80%+1.42%+6.26%-83.58%+313.96%-56.18%-71.80%+966.65%-88.39%+1600.53%+108.81%+39.13%+17.60%+27.81%+154.77%+63.55%+77.89%
Cost of Revenue987.00K527.00K1.90M--1.68M-1.71M-1.82M-398.77K3.33M2.29M1.73M526.00K745.00K8.44M15.25M17.24M15.90M14.42M27.35M38.35M72.83M
Gross Profit----1.68M1.71M1.82M697.12K-2.09M-1.75M-1.58M1.10M-556.00K-5.23M-8.54M-7.90M-4.92M-384.00K8.41M20.12M31.19M
Gross Margin----99.87%99.98%100.03%233.66%-169.26%-323.22%-1033.34%67.69%-294.18%-162.63%-127.24%-84.60%-44.84%-2.74%23.51%34.41%29.98%
Operating Expense----3.31M3.97M3.93M5.12M3.60M4.55M6.02M10.51M12.47M21.53M27.89M40.97M79.27M133.52M142.15M144.18M152.17M
Operating Income-----1.63M-2.26M-2.11M-4.42M-5.69M-6.30M-7.60M-9.41M-13.03M-26.76M-36.43M-48.87M-84.19M-133.91M-133.75M-124.05M-120.98M
Operating Margin-----96.64%-132.01%-116.29%-1481.47%-460.79%-1163.68%-4977.80%-578.07%-6891.53%-832.64%-542.86%-523.36%-766.77%-954.15%-374.07%-212.14%-116.30%
EBITDA-----1.45M-2.21M-1.99M-3.51M-4.45M-4.87M-6.33M-8.73M-12.67M-21.27M-23.04M-36.96M-73.22M-120.07M-118.82M-95.53M-96.59M
EBITDA Margin-----85.86%-129.51%-109.36%-1175.95%-360.63%-899.52%-4145.53%-536.43%-6703.70%-661.67%-343.24%-395.89%-666.89%-855.56%-332.33%-163.36%-92.85%
Net Income-----1.72M-2.35M-2.10M-4.39M-5.60M-6.19M-7.58M-9.41M-13.03M-25.62M-33.67M-47.45M-82.14M-132.70M-134.15M-118.73M-137.42M
Net Income Margin-----102.10%-137.70%-115.59%-1472.30%-453.26%-1144.16%-4966.72%-578.13%-6892.59%-797.17%-501.79%-508.14%-748.11%-945.56%-375.20%-203.03%-132.11%
R&D------------179.00K3.42M4.79M8.19M12.53M19.46M19.36M22.17M22.85M
R&D as % of Total Revenue------------94.71%106.57%71.38%87.68%114.09%138.68%54.16%37.91%21.97%
Interest Expense0000138.88K121.61K95.78K24.71K9.57K5.75K2.47K1.00K2.00K2.00K3.00K122.00K79.00K430.00K798.00K1.03M17.25M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%8.24%7.11%5.27%8.28%0.77%1.06%1.62%0.06%1.06%0.06%0.04%1.31%0.72%3.06%2.23%1.76%16.59%

Balance Sheet

Currency: SEK2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets9.70M10.77M13.66M23.16M21.18M25.92M31.66M33.23M38.63M46.32M47.80M156.31M166.03M197.16M187.76M258.89M174.62M322.68M433.54M426.36M369.81M
Total Liabilities3.00M3.22M4.33M4.83M4.56M4.03M3.79M1.25M1.17M2.24M1.99M24.44M25.57M29.75M24.07M27.55M24.04M60.78M58.06M80.51M65.35M
Total Equity6.70M7.55M9.33M18.34M16.61M21.90M27.87M31.99M37.46M44.08M45.81M131.87M140.46M167.41M163.69M231.35M150.58M261.90M375.48M345.86M304.46M
Cash273.00K96.00K547.00K5.10M574.84K2.31M5.07M5.74M10.11M3.14M14.48M10.03M8.74M32.67M30.90M160.31M74.87M26.04M151.01M100.94M73.97M
Total Debt---3.85M3.71M3.01M543.81K300.50K185.00K121.00K37.00K--273.00K388.00K2.40M1.63M13.04M11.47M22.67M14.01M
Net Debt----1.25M3.13M698.17K-4.53M-5.44M-9.92M-3.02M-14.44M-10.03M-8.74M-32.39M-30.51M-157.91M-73.24M-12.99M-139.54M-78.27M-59.96M

Cash Flow

Currency: SEK2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-129.00K---1.60M-2.12M-1.95M-6.06M-5.43M-3.85M-6.41M-10.00M-12.29M-17.73M-27.14M-38.34M-81.33M-136.78M-113.91M-105.94M-109.10M
Investing Cash Flow-----2.75M-3.04M-3.05M-1.50M-1.16M-3.00M-4.34M-7.35M-10.03M-9.44M-3.77M-327.00K-2.97M-4.98M-7.82M-20.34M-18.10M
Financing Cash Flow667.00K990.00K2.96M10.88M-169.31K6.90M7.76M8.23M10.96M-114.00K22.09M12.90M21.03M51.10M29.13M167.69M-945.00K92.36M246.51M68.21M100.81M
Capital Expenditure60.00K6.00K088.00K2.75M3.04M3.05M1.50M1.16M3.00M4.34M6.56M10.03M9.44M3.77M327.00K2.97M5.11M7.82M20.34M2.74M
Free Cash Flow-----4.36M-5.16M-5.00M-7.56M-6.59M-6.85M-10.76M-16.56M-22.32M-27.17M-30.90M-38.66M-84.30M-141.89M-121.73M-126.28M-111.84M
FCF to OCF----271.72%243.50%256.19%124.73%121.34%178.10%167.70%165.53%181.58%153.23%113.88%100.85%103.66%103.73%106.87%119.20%102.52%

Earnings

Report DateJun 30, 2013Dec 31, 2013May 18, 2015Aug 26, 2015Nov 24, 2015Feb 18, 2016Apr 27, 2016Aug 31, 2016Nov 22, 2016Feb 16, 2017May 23, 2017Aug 31, 2017Nov 28, 2017Feb 16, 2018May 8, 2018Aug 22, 2018Nov 8, 2018Feb 15, 2019May 8, 2019Aug 22, 2019Nov 8, 2019Feb 14, 2020May 8, 2020Aug 21, 2020Nov 6, 2020Feb 26, 2021May 6, 2021Aug 27, 2021Nov 12, 2021Feb 17, 2022May 5, 2022Jul 15, 2022Nov 10, 2022Feb 1, 2023Apr 28, 2023Aug 24, 2023Oct 26, 2023Feb 15, 2024May 7, 2024Aug 26, 2024Nov 6, 2024Feb 17, 2025Apr 22, 2025Jul 18, 2025Nov 4, 2025Feb 19, 2026Apr 20, 2026Jul 17, 2026Oct 29, 2026
EPS Estimate----------------------1.59--------------0.33-0.30-0.30-0.30-0.20-0.20-0.20-0.24-0.19-----
EPS Actual-0.12-0.08-0.12-0.14-0.11-0.10-0.11-0.08-0.06-0.10-0.11-0.07-0.06-0.09-0.10-0.12-0.12-0.23-0.18-0.17-0.15-0.18-0.17-0.22-0.20-0.26-0.27-0.35-0.31-0.38-0.33-0.63-0.74-0.61-0.42-0.42-0.33-0.33-0.23-0.28-0.26-0.20-0.27-0.24-0.16-0.27-0.14-0.14-
Surprise---------------------88.68%--------------27.27%-10.00%-10.00%23.33%-40.00%-30.00%0.00%-12.50%-26.32%-----
Timing--Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-market-After-hours

Key Statistics & Ratios

Market Cap449.64M
Enterprise Value385.94M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales4.38
Price / Book1.52
EPS-0.71
Book Value1.68
Revenue (TTM)102.73M
Gross Profit (TTM)33.92M
EBITDA-111.85M
Profit Margin-109.30%
Operating Margin-94.58%
Return on Equity-35.35%
Return on Assets-18.57%
Shares Outstanding157.22M
Shares Float107.47M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 16, 2023948:935
  • Mar 9, 2017585:574
  • May 26, 201628:27
  • Nov 27, 201432:29
  • May 20, 2013520:471
  • Aug 22, 2012515:502
  • Feb 2, 201145:43
  • Jan 5, 2010975:943